4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow FS 069: new trials by email Literature Review of FS 069 trials Research Report on FS 069
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Determine Safety and Dosage of OPTISON in Pediatric Participants Optison - Transthoracic Echocardiography, Suspected or Known Structural or Functional Cardiac Abnormality | Phase 4 | Completed | GE Healthcare | 39 | 2020-12-01 | 2024-05-17 |
| IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys? Optison, Ultrasound (US), Contrast-enhanced ultrasound (CEUS) - Transplantation, Kidney | Phase 4 | Completed | Mayo Clinic | 40 | 2015-11-01 | 2020-03-02 |
| Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR). Optison (Perflutren Protein-Type A Microspheres Injectable Suspension), Dextrose - Pulmonary Hypertension | Phase 4 | Completed | GE Healthcare | 30 | 2009-03-01 | 2012-08-24 |
| A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice. Perflutren Protein-Type A Microspheres Injectable Suspension, United States Pharmacopeia (USP) - Echocardiography | Phase 4 | Completed | GE Healthcare | 1039 | 2008-05-01 | 2012-06-12 |
GE Healthcare (3) · Mayo Clinic (1)
United States (4)
Christopher Jefferds (1) · David Thompson, MD, PhD (1) · J Kriegshauser, MD (1) · Rubin Sheng, MD (1)